Suppr超能文献

新型 IMP 脱氢酶抑制剂苯甲酰胺核糖苷与替唑呋林和硒唑呋林的生化参数比较。

Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin.

作者信息

Gharehbaghi K, Sreenath A, Hao Z, Paull K D, Szekeres T, Cooney D A, Krohn K, Jayaram H N

机构信息

Laboratory for Experimental Oncology, Indiana University School of Medicine, Indianapolis 46202-5200.

出版信息

Biochem Pharmacol. 1994 Oct 7;48(7):1413-9. doi: 10.1016/0006-2952(94)90565-7.

Abstract

The biochemical and cytotoxic activities of the IMP dehydrogenase (IMPDH) inhibitors benzamide riboside, tiazofurin, and selenazofurin were compared. These three C-nucleosides exert their cytotoxicity by forming an analogue of NAD, wherein nicotinamide is replaced by the C-nucleoside base. The antiproliferative activities of these three agents were compared in a panel of 60 human cancer cell lines. To examine the relationship of benzamide riboside and selenazofurin to tiazofurin, COMPARE computer analysis was performed, and correlation coefficients of 0.761 and 0.815 were obtained for benzamide riboside and selenazofurin, respectively. The biochemical activities of these agents were examined in human myelogenous leukemia K562 cells. Incubation of K562 cells for 4 hr with 10 microM each of benzamide riboside, selenazofurin and tiazofurin resulted in a 49, 71, and 26% decrease in IMPDH activity with a concurrent increase in intracellular IMP pools. As a consequence of IMPDH inhibition, GTP and dGTP concentrations were curtailed. These studies demonstrated that selenazofurin was the most potent of the three agents. To compare the cellular synthesis of NAD analogues of these agents, K562 cells were incubated with 10 microM each of benzamide riboside, tiazofurin and selenazofurin after prelabeling the cells with [2,8-3H]adenosine. The results demonstrated that benzamide riboside produced 2- and 3-fold more of NAD analogue (BAD) than tiazofurin and selenazofurin did. To elucidate the effects of the three compounds on other NAD-utilizing enzymes, the inhibitory activities of purified benzamide adenine dinucleotide (BAD), thiazole-4-carboxamide adenine dinucleotide (TAD) and selenazole-4-carboxamide adenine dinucleotide (SAD) were studied in commercially available purified preparations of lactate dehydrogenase, glutamate dehydrogenase and malate dehydrogenase. TAD and SAD did not inhibit these three dehydrogenases. Although BAD did not influence lactate and glutamate dehydrogenases, it selectively inhibited 50% of malate dehydrogenase activity at a 3.2 microM concentration. These studies demonstrate similarities and differences in the biochemical actions of the three C-nucleosides, even though they share similar mechanisms of action.

摘要

对肌苷 5'-单磷酸脱氢酶(IMPDH)抑制剂苯甲酰胺核糖苷、噻唑呋林和硒唑呋林的生化及细胞毒性活性进行了比较。这三种 C-核苷通过形成 NAD 的类似物发挥其细胞毒性,其中烟酰胺被 C-核苷碱基取代。在一组 60 种人类癌细胞系中比较了这三种药物的抗增殖活性。为了研究苯甲酰胺核糖苷和硒唑呋林与噻唑呋林的关系,进行了 COMPARE 计算机分析,苯甲酰胺核糖苷和硒唑呋林的相关系数分别为 0.761 和 0.815。在人髓性白血病 K562 细胞中检测了这些药物的生化活性。用 10μM 的苯甲酰胺核糖苷、硒唑呋林和噻唑呋林分别孵育 K562 细胞 4 小时,导致 IMPDH 活性分别降低 49%、71%和 26%,同时细胞内 IMP 池增加。由于 IMPDH 受到抑制,GTP 和 dGTP 浓度降低。这些研究表明,硒唑呋林是这三种药物中最有效的。为了比较这些药物的 NAD 类似物的细胞合成情况,在用[2,8-3H]腺苷预标记细胞后,用 10μM 的苯甲酰胺核糖苷、噻唑呋林和硒唑呋林分别孵育 K562 细胞。结果表明,苯甲酰胺核糖苷产生的 NAD 类似物(BAD)比噻唑呋林和硒唑呋林多 2 至 3 倍。为了阐明这三种化合物对其他利用 NAD 的酶的影响,在市售的纯化乳酸脱氢酶、谷氨酸脱氢酶和苹果酸脱氢酶制剂中研究了纯化的苯甲酰胺腺嘌呤二核苷酸(BAD)、噻唑-4-甲酰胺腺嘌呤二核苷酸(TAD)和硒唑-4-甲酰胺腺嘌呤二核苷酸(SAD)的抑制活性。TAD 和 SAD 不抑制这三种脱氢酶。虽然 BAD 不影响乳酸脱氢酶和谷氨酸脱氢酶,但在 3.2μM 浓度下它选择性地抑制了 50%的苹果酸脱氢酶活性。这些研究表明,尽管这三种 C-核苷具有相似的作用机制,但其生化作用存在异同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验